Better Knowledge about Testicular Cancer Might Improve the Rate of Testicular (Self-)Examination: A Survey among 1,025 Medical Students in Germany.
Awareness
Germany
Medical students
Testicular cancer
Testicular self-examination
Journal
Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
03
2022
accepted:
20
06
2022
pubmed:
29
7
2022
medline:
20
10
2022
entrez:
28
7
2022
Statut:
ppublish
Résumé
Testicular cancer (TC) is the most common malignancy among young men. Public awareness of the disease and testicular (self-)examination (TSE) is low. This study aims to evaluate the awareness of German medical students on TC. A 25-item questionnaire on TC was handed out during a medical student's football tournament in Germany. Data collection was anonymous. Questionnaires were answered by 573 (56%) female and 452 (44%) male medical students. Most students had gaps in their knowledge about TC: 483 (48%) students knew, the most common age at which TC occurs, and 413 (41%) knew its cure rate. Having dealt with TC during their studies was significantly associated with a better knowledge about TC (p = 0.001). These students also had a higher rate of TSE among male students (66% vs. 52%, p = 0.002). This also applies to examining the partner's testicles by female students (25% vs. 13%, p < 0.001). Even in a positively selected collective like medical students, the knowledge about TC is low. Better knowledge might improve the chance of detecting the disease early. Therefore, our joint project of urologists, patients, and supporters called Prevention and Advocacy of Testicular Education e.V. (PATE) works on rising public TC awareness in Germany.
Identifiants
pubmed: 35901778
pii: 000525854
doi: 10.1159/000525854
pmc: PMC9677845
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1056-1060Informations de copyright
© 2022 The Author(s). Published by S. Karger AG, Basel.
Références
Eur Urol. 2017 Feb;71(2):290-298
pubmed: 27649970
Prev Med Rep. 2016 Apr 21;3:361-6
pubmed: 27419037
Urol Oncol. 2013 Apr;31(3):386-91
pubmed: 21429771
Asian Pac J Cancer Prev. ;17(11):4999-5003
pubmed: 28032730
Ir J Med Sci. 2020 Aug;189(3):811-815
pubmed: 31838732
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 May-Jun;50(5-6):836-50
pubmed: 17514470
J Clin Oncol. 2015 Jan 1;33(1):51-7
pubmed: 25135991
Urologe A. 2021 Jul;60(7):901-909
pubmed: 33651118
Curr Clin Pharmacol. 2018;13(4):210-215
pubmed: 30084336
Am J Mens Health. 2018 Sep;12(5):1510-1516
pubmed: 29717912
J Cancer Educ. 2018 Apr;33(2):398-403
pubmed: 27815814
Curr Urol. 2020 Jun;14(2):92-97
pubmed: 32774234
Urologe A. 2019 Nov;58(11):1331-1337
pubmed: 31559444
HRB Open Res. 2018 May 14;1:16
pubmed: 32002508
BMC Cancer. 2018 Jan 4;18(1):21
pubmed: 29301513
Andrology. 2015 Jan;3(1):4-12
pubmed: 25331326
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):645-661
pubmed: 29461592
Pan Afr Med J. 2019 Jun 06;33:85
pubmed: 31489063
Eur Urol. 2002 Dec;42(6):553-62; discussion 562-3
pubmed: 12477650
Urologe A. 2019 Jul;58(7):790-794
pubmed: 31028422